Tolbutamide

Tolbutamide yɛ aduro a wɔde sa Asikyire yadeɛ bi a yɛfrɛ no type 2 diabetes. Tolbutamide pu nsuo bi a yɛfrɛ no insulin. Nipadua no akwaa bi a frɛ no pancreas mu na insulin wɔ.( Pancreas) wɔ yafunu mu. Ɛsiane sɛ obi fa tolbutamide a akyire nsunsuansoɔ no bi nhyɛ da nyɛ adeɛ a wɔn ani gye ho nti, wɔntaa mfa. Ɛnte sɛ afoforɔ bi a ɛnnɛ yi wɔtaa de di dwuma mu. Nhwehwɛmu kyerɛ sɛ mpanimfoɔ na ɛtaa yɛ ma wɔn pa ara . Afe Apem, ahankron ne aduonum nsia no mu na wɔhunuiɛ.^[1]

Nsunsuansoɔ

Sɛ obi fa aduro yi a, ɛso nsunsuansoɔ no bi ne sɛ ɛma no yɛ kɛseɛ.^[2]

Beaeɛ a Menyaa Mmoa Firiiɛ

↑ Walker SR (2012). Trends and Changes in Drug Research and Development (in English). Springer Science & Business Media. p. 109. ISBN 978-94-009-2659-2.
↑ Kalra, S. (2015). "Sulfonylureas and their use in clinical practice". Veterinary Record Open. Termedia Publishing. 1 (1): e000080. doi:10.1136/vetreco-2014-000080. PMC 4562452. PMID 26392882.

[Wal2012-1] Walker SR (2012). Trends and Changes in Drug Research and Development (in English). Springer Science & Business Media. p. 109. ISBN 978-94-009-2659-2.

[Kalra2015-2] Kalra, S. (2015). "Sulfonylureas and their use in clinical practice". Veterinary Record Open. Termedia Publishing. 1 (1): e000080. doi:10.1136/vetreco-2014-000080. PMC 4562452. PMID 26392882.

[1]

[2]